Study / S4Q4JA3A42022-11-05

Deciphering the impact of genetic variation on human polyadenylation using APARENT2

Johannes Linder, Samantha E. Koplik, Anshul Kundaje, Georg Seelig

About this study

Background: 3′-end processing by cleavage and polyadenylation is an important and finely tuned regulatory process during mRNA maturation. Numerous genetic variants are known to cause or contribute to human disorders by disrupting the cis-regulatory code of polyadenylation signals. Yet, due to the complexity of this code, variant interpretation remains challenging. Results: We introduce a residual neural network model, APARENT2, that can infer 3′-cleavage and polyadenylation from DNA sequence more accurately than any previous model. This model generalizes to the case of alternative polyadenylation (APA) for a variable number of polyadenylation signals. We demonstrate APARENT2’s performance on several variant datasets, including functional reporter data and human 3′ aQTLs from GTEx. We apply neural network interpretation methods to gain insights into disrupted or protective higher-order features of polyadenylation. We fine-tune APARENT2 on human tissue-resolved transcriptomic data to elucidate tissue-specific variant effects. By combining APARENT2 with models of mRNA stability, we extend aQTL effect size predictions to the entire 3′ untranslated region. Finally, we perform in silico saturation mutagenesis of all human polyadenylation signals and compare the predicted effects of >43 million variants against gnomAD. While loss-of-function variants were generally selected against, we also find specific clinical conditions linked to gain-of-function mutations. For example, we detect an association between gain-of-function mutations in the 3′-end and autism spectrum disorder. To experimentally validate APARENT2’s predictions, we assayed clinically relevant variants in multiple cell lines, including microglia-derived cells. Conclusions: A sequence-to-function model based on deep residual learning enables accurate functional interpretation of genetic variants in polyadenylation signals and, when coupled with large human variation databases, elucidates the link between functional 3′-end mutations and human health.

Full author list & citation

Johannes Linder, Samantha E. Koplik, Anshul Kundaje, Georg Seelig. Deciphering the impact of genetic variation on human polyadenylation using APARENT2. 2022-11-05. https://doi.org/10.1186/s13059-022-02799-4

Experiments 3

E5V0XN2O4

HEK293T APA variant MPRA

An episomal mCherry reporter MPRA tested reference and variant 250-nt oligo libraries containing PAS-centered sequences in HEK293T cells. Cleavage profiles were measured by UMI-collapsed paired-end MiSeq RNA sequencing for two biological replicates; the table reports proximal cleavage log-odds ratios and APARENT2 predictions.

Episomal Plasmid MPRAHumanhg19
Explore data
E7CN167WU

HMC3 APA variant MPRA

An episomal mCherry reporter MPRA tested reference and variant 250-nt oligo libraries containing PAS-centered sequences in HMC3 cells. Cleavage profiles were measured by UMI-collapsed paired-end MiSeq RNA sequencing for two biological replicates; the table reports proximal cleavage log-odds ratios and APARENT2 predictions.

Episomal Plasmid MPRAHumanhg19
Explore data
E7EWIHJUL

SK-N-SH APA variant MPRA

An episomal mCherry reporter MPRA tested reference and variant 250-nt oligo libraries containing PAS-centered sequences in SK-N-SH cells. Cleavage profiles were measured by UMI-collapsed paired-end MiSeq RNA sequencing for two biological replicates; the table reports proximal cleavage log-odds ratios and APARENT2 predictions.

Episomal Plasmid MPRAHumanhg19
Explore data

Raw source data 9 files

Original supplemental and deposited inputs retained for this study. Download files individually or together as a ZIP; nested folders are preserved. Source reuse terms apply, and sequencing reads may be omitted.

Download all 9 files (ZIP)13059_2022_2799_MOESM1_ESM.pdf13059_2022_2799_MOESM2_ESM.xlsxGSE214825_apa_100_variants_library_metadata.txt.gzGSE214825_apa_100_variants_rev2_20220621_hek293_v3_umi_mut_0.csv.gzGSE214825_apa_100_variants_rev2_20220621_hmc3_v3_umi_mut_0.csv.gzGSE214825_apa_100_variants_rev2_20220621_sknsh_v3_umi_mut_0.csv.gzGSE214825_family.soft.gzGSE214825_series_matrix.txt.gzREADME.txt

Cite OpenMPRA

Cite the OpenMPRA database. Include your access date because the collection changes over time.

Please also cite the source studies when using their data.